SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-22-000006
Filing Date
2022-01-04
Accepted
2022-01-04 17:02:24
Documents
12
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20220103.htm   iXBRL 8-K 32943
  Complete submission text file 0000899923-22-000006.txt   167340

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220103.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220103_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220103_pre.xml EX-101.PRE 12634
6 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220103_htm.xml XML 10816
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 22507153
SIC: 2835 In Vitro & In Vivo Diagnostic Substances